Beta-cell replacement by transplantation in diabetes mellitus: Which patients at what risk, which way (when pancreas, when islets), and how to allocate deceased donor pancreases

Current Opinion in Organ Transplantation

Volumn 10, Issue 2, 2005, Pages 147-149

  Sutherland, David E R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CLINICAL PROTOCOL; DIABETES MELLITUS; EDITORIAL; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; LIVING DONOR; MEDICAL DECISION MAKING; MORBIDITY; ORGAN ALLOCATION POLICY; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PATIENT SELECTION; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; UNITED NETWORK OF ORGAN SHARING;

EID: 21044443892     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mot.0000163647.34011.a3     Document Type: Editorial

References (17)

1. Stock P. Beta-cell replacement for type 1 diabetes mellitus-islet verus solid organ panceas. Curr Opin Organ Transplant 2005; 10:70-74.
2. Boggi U, Vistoli F, DelChiaro M, et al. Surgical Techniques for Pancreas Transplantation. Curr Opin Organ Transplant 2005; 10:75-87.
3. Kaufmann D, Salvalaggio PRO. Immunosuppression for pancreas transplantation. Curr Opin Organ Transplant 2005; 10:88-94.
4. Robetson RP. 2005 update: Impact of pancreas and islet transplantation on acute and chronic complications of diabetes. Curr Opin Organ Transplant 2005; 10:95-99.
5. Sutherland DER, Gruessner, A, Hering J. Beta-cell replacement therapy [pancreas and islet transplantation]: an integrated approach. Endocr Metab Clin N Amer 2004; 33:135-148
6. Sutherland DER. Pancreas and islet transplant population. In Transplantation of the Pancreas [editors Gruessner RWG, Sutherland DER], New York, Springer-Verlag, 2004; pp. 91-92.
7. Matsumoto I, Sawada T, Nakano M, et al. Improvements in islet yield from obese donors for human islet transplants. Transplantation 2004; 78:880-885.
8. Nakano M, Matsumoto I, Sawada T, et al. Capsase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves graft function. Pancreas 2004; 29:104-109.
9. Sutherland DER, Kandaswamy R, Humar A, Gruessner RWG. Calcineurin-inhibitor-free protocols: Use of the anti-T-cell agent Campath H-1 for maintenance immunosuppression in pancreas and pancreas/kidney recipients. Clinical Transplantation 2004; 18[Suppl 13]:14-15.
10. Hering BJ, Kandaswamy R, Ansite J, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes mellitus. J Am Med Assoc 2005; 293:830-835.
11. Sutherland DER, Gruessner RW, Jie T, et al. Pancreatic islet auto-transplantation for chronic pancreatitis. Clinical Transplantation 2004; 18[Suppl 13]: 17-18.
12. Gruessner RWG, Sutherland DE, Dunn DL, et al. Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg 2004; 198:559-567.
13. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
14. Sutherland DER, Gores PF, Farney AC, et al. Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg 1993; 166:456-491.
15. Gruessner AC, Sutherland DER. Pancreas transplant outcomes for United States [US] and non-US cases as reported to the United Network for Organ Sharing [UNOS] and the International Pancreas Transplant Registry [IPTR] as of May 2003. In: Cecka JM, Terasaki PI, editors. Clinical Transplants 2003. Los Angeles: UCLA Immunogenetics Center, 2004; pp. 21-51.
16. Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. J Am Med Assoc 2003; 290:2817-2823.
17. Gruessner RWG, Sutherland DER, Gruessner AW. Mortality assessment in pancreas transplants. Am J Transplantation 2004; 4:2018-2026.